CAPSULS™ Patient Isolation Unit
EXPORT RESTRICTIONS: Product shown herein is subject to US export regulations and may require a license prior to export. Any diversion contrary to US Government regulations is prohibited.
IMPORTANT: For more information and availability, please submit a request through an email contact form. Shipping for this item will be determined upon product availability and will be billed separately.
CAPSULS™ is a portable patient isolation unit (PIU) which prevents particulate (biological and radiological) cross-contamination between the patient and the external environment. This unit includes features that enable medical intervention to the patient via end-user supplied medical equipment. CAPSULS™ is intended to be used in the:Transportation and isolation of patients on aircraft, ambulances, ships, and any vehicle capable of safely relocating a patient on a standard litter.Temporary isolation with or without transport of patients within hospitals or other medical facilities.
Key Features:
Unrivaled Portability
- Compacts down to a manageable size of 24" x 20" x 18" (0.61m x 0.50m x 0.46m)
- Weighs in at just around 30 lbs. (14 kg)
- Easily deployed and fully operational within 10 minutes
Regulation:
CAPSULS™ is a Regulatory Class II device. It has been cleared by the FDA for marketing in the U.S. (510(k) K052798).
It has been cleared class II medical device. U.S. Patent: 6,241,653
ORCA System Testing :
- Pathogen Passage Requirements
- Chemical Agent Permeation
- Aerosol Leakage
- Liquid Penetration
- Comfort Level (Temp./Humidity variants while recording vitals)
- Hoisting operations
- TTP’s completed by U.S. Coast Guard Material certified to NFPA 1994-2012 Standard on Protective ensembles for First Responders to CBRN Terrorism Incidents, Class 3.
- Meets the requirements for the resistance of materials used in protective clothing against penetration of blood borne pathogens per ASTM F1671M-13.
- Has been tested and shown to meet and exceed US Military Target Performance Value (TPV) requirements for withstanding permeation by chemical warfare agents (CWA) per the U.S. Army’s Test Operations Procedure (TOP) 8-2-501.